Fibrolamellar Cancer Foundation Research Grant Program

About this program

The Fibrolamellar Cancer Foundation (FCF) funds innovative research aimed at improving understanding, diagnosis, epidemiology, and treatment of fibrolamellar carcinoma (FLC), with emphasis on novel therapies and clinical trials leading toward a cure. Applicants must be employed by institutions engaged in health-related research and propose projects focused specifically on FLC. Funded research must support collaboration and open sharing of data and resources; grantees must submit semiannual financial and scientific progress reports. Applications are reviewed three times annually, with deadlines of March 1, July 1, and November 1, while time-sensitive proposals may be considered year-round with prior approval.